The drug met the primary and key secondary endpoints, delivering superior A1C reduction and Novo Nordisks triple agonist UBT251 delivered a mean weight loss of 19.7% after 24 weeks in a Phase 2 trial in China, the company announced on Tuesday
Over 1700 Google Reviews Great experience
For most people, a lack of weight loss after one week in a calorie deficit is a normal and expected part of the process, requiring patience rather than medical intervention
New England Journal of Medicine , 375 (4), 311322
If you have previous experience with semaglutide or another GLP-1 agonist and tolerated it well, starting at the standard 2.5 mg is usually fine
Accidental interaction with used Mounjaro pens may harm kids, adults, and pets